Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Background: To evaluate the efficacy and toxicity of combination gemcitabine plus cisplatin (GC) chemotherapy in metastatic or recurrent nasopharyngeal carcinoma (NPC). Patients and methods: Forty-four patients of Chinese ethnicity with metastatic or recurrent NPC received ambulatory GC chemotherapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2002-08, Vol.13 (8), p.1252-1258
Hauptverfasser:	Ngan, R. K. C., Yiu, H. H. Y., Lau, W. H., Yau, S., Cheung, F. Y., Chan, T. M., Kwok, C. H., Chiu, C. Y., Au, S. K., Foo, W., Law, C. K., Tse, K. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adult Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - secondary Chemotherapy Cisplatin - administration & dosage Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Female gemcitabine Hematologic Diseases - chemically induced Humans Key words: cisplatin Male Medical sciences metastasis Middle Aged nasopharyngeal carcinoma Nasopharyngeal Neoplasms - drug therapy Nasopharyngeal Neoplasms - pathology Neoplasm Recurrence, Local - drug therapy Pharmacology. Drug treatments phase II recurrence Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!